Latest News

Vitalant Foundation Launches Legacy Fund to Honor Dr. Michael P. Busch

The Vitalant Foundation today publicly launched a $1 million fundraising campaign to support further innovation and advances in blood and biotherapies, establishing the Dr. Michael P. Busch First Response Fund.
Assessing RBC transfusion efficacy in chronic transfusion recipients: advancing precision transfusion medicine

n this issue of Blood Transfusion, Karafin et al.1 describe a study protocol to measure transfusion outcomes in chronic transfusion recipients in the US and Brazil.
The Red Blood Cell-Improving Transfusions for Chronically Transfused Recipients (RBC-IMPACT) study: protocol description of an international multi-site observational clinical study

Variability in blood donors, components, and recipients are known to affect transfusion outcomes, yet the combined effects of these factors remains unclear.